abstract |
There is provided combination products comprising: (a) pemirolast, or suplatast, or a pharmaceuticaily-acceptable salt or solvate of either of those compounds; and (b) seratrodast, or a pharmaceuticaily-acceptable salt or solvate thereof. Such combination products find particular utility in the treatment of atherosclerosis and related conditions. |